This is a randomized, double-blind, placebo-controlled study with an open-label extension (OLE).
- Investigators
- Christopher Harden, Divya C Patel
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Research at a glance
Top areas of exploration
- Sarcoidosis , 3 publications
- Lung Diseases, Interstitial , 3 publications
- Lung , 2 publications
- Alveolitis, Extrinsic Allergic , 2 publications
Research activity
Active clinical trials
This is a randomized, double-blind, placebo-controlled phase 2b trial in subjects with IPF (idiopathic pulmonary fibrosis) investigating the efficacy and safety of GB0139.
- Investigators
- Christopher Harden, Divya C Patel
- Status
- Accepting Candidates
- Ages
- 40 Years - N/A
- Sexes
- All
This is a Phase 2, multicenter, multinational, randomized, double-blind, placebo-controlled study evaluating the efficacy, safety, pharmacokinetics (PK), quality of life and exploratory pharmacodynamics (PD) of two treatment doses of CC-90001, 200…
- Investigator
- Divya C Patel
- Status
- Accepting Candidates
- Ages
- 40 Years - N/A
- Sexes
- All
My publications
Filter publications
28 publications
2022
Prevalence and Characteristics of Hyperthyroidism Among Patients With Sarcoidosis in the United States.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
PubMed • Publisher's site2022
Rationale and design of the SARCoidosis Outcomes in all respiratory Viral Infectious Diseases (SARCOVID) Study.
BMJ open respiratory research
PubMed • Publisher's site2022
Treatment of Hypersensitivity Pneumonitis (HP).
American journal of respiratory and critical care medicine
PubMed • Publisher's site2021
A 29-Year-Old Woman With Cough, Dry Eyes, Pulmonary Cysts, and Nodules.
Chest
PubMed • Publisher's site2021
Clinical Characteristics of Sarcoidosis Patients with Self-Reported Lymphoma: A US Nationwide Registry Study
Lung
PubMed • Publisher's site